SXT and Taxo A Disks for Presumptive Identification of Group A and B Streptococci in Throat Cultures
A bacitracin (0.04 units, BBL)-SXT (trimethoprim, 1.25 mg, plus sulfamethoxazole, 23.75 mg, BBL) susceptibility test was 94% accurate in presumptively identifying streptococci as either group A, B or not group A and B.
Guardat en:
| Publicat a: | J Clin Microbiol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1976
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC274426/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/965480/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.4.2.192-193.1976 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|